NCT02636816View on ClinicalTrials.gov

Cardiovascular Effects of Carbetocin Given During Elective Cesarean

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Effect of Carbetocin on Cardiovascular SystemPregnancy
Interventions
DRUG

carbetocin

drug used to increase the tone of uterine muscle to prevent post partum hemorrhage after cesarean delivery.

Trial Locations (1)

V6H 3N1

BC Women's Hospital, Vancouver

Sponsors

Collaborators (1)

Edwards Lifesciences
All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

University of British Columbia

OTHER